NCT04328753

Brief Summary

Forty-five adult male patients with generalized gingivitis participated in the double blinded randomized controlled parallel study divided into three groups, two mouth rinses and distilled water( negative control) used during seven days periods as adjunctive to regular mechanical oral hygiene, one group received super oxidized water mouth rinses(microsafe®) three times daily and the second group received Alcohol-free chlorhexidine 0.12% solution(kin gingival®) twice dialy and the third group received distilled water (negative control). The first visit included PLI measurement after that we removed the supra gingival plaque by cotton roll to avoid contamination with the periopaper strip during GCF collection, then GCF collected from targeted sites(upper incisors, labial side) after that the other clinical periodontal parameters ( GI and BOP) were measured and then scaling was done after sample collection because of gingival bleeding which occur during scaling then inform the patient to use the coded bottle which gave to the participant by the assistant not involve in the study so the researcher did not know the type of mouthwash that was given to the participant( CHX twice daily while SOW three times daily) .The mouthwashes was given for one week with routine mechanical dental home care(brushing and flossing).The codded bottle was gave randomly by a decision on that day for example on Sunday we gave all the participants code 1 and on other days we gave to other participants code 2 or code 3. In the second visit the PLI was measured first , then the sample was collected from the same teeth after that the other periodontal parameters were collected again ( GI and BOP).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Apr 2020

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 31, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

April 1, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2020

Completed
Last Updated

April 22, 2020

Status Verified

April 1, 2020

Enrollment Period

2 months

First QC Date

March 24, 2020

Last Update Submit

April 20, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • measuring interleukin -1 beta

    measure interleukin -1 beta in gingival crevicular fluid by using ELISA

    one week

Secondary Outcomes (3)

  • measuring plaque accumulation

    one week

  • measuring gingival inflammation

    one week

  • measure the gingival sulcus erosion

    one week

Study Arms (3)

super oxidized water group

EXPERIMENTAL
Drug: Super Oxide water

chlorhexidene group

ACTIVE COMPARATOR
Drug: Chlorhexidine mouthwash

distilled water

PLACEBO COMPARATOR
Other: Distilled water

Interventions

Microsafe®, a recently available super-oxidized solution for gingival care, offers a completely improved approach for treatment of gingivitis. The neutral pH, super oxidized water was certified as an antiseptic .

Also known as: SOW
super oxidized water group

CHX is a regular bisbiguanide artificial antiseptic containing of two biguanide groups and four chlorophenyl rings linked by a hexamethylene bridge. The dicationic nature of CHX makes it interacting strongly with anions, which is related to its safety, efficacy, and side effects. It is available in three forms, digluconate, acetate and hydrochloride salts. CHX has broad spectrum antimicrobial activity

Also known as: CHX
chlorhexidene group

act as a negative control in this study

Also known as: D.W
distilled water

Eligibility Criteria

Age15 Years - 45 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsForty-five adult male patients with generalized gingivitis
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • \. patient with generalized gingivitis. 2. no antibiotic treatment during a 3-month period prior to the start of the trial.
  • \. no regular medication with anti-inflammatory compounds. 4. no history of allergy to oral care products. 5. no regular use of oral antiseptics.

You may not qualify if:

  • \. Patients who refuse to write an informed consent form. 2. Smokers. 3. Female patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baghdad university college of dentistry

Baghdad, +964, Iraq

RECRUITING

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
third professional person give the one of opaque coded bottle to the participant
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Forty-five adult male patients with generalized gingivitis participated in the double blinded randomized controlled parallel study divided into three groups, two mouth rinses and distilled water( negative control) used during seven days periods as adjunctive to regular mechanical oral hygiene, one group received super oxidized water mouth rinses(microsafe®) three times daily and the second group received Alcohol-free chlorhexidine 0.12% solution(kin gingival®) twice dialy and the third group received distilled water (negative control).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist dentist

Study Record Dates

First Submitted

March 24, 2020

First Posted

March 31, 2020

Study Start

April 1, 2020

Primary Completion

May 20, 2020

Study Completion

June 24, 2020

Last Updated

April 22, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations